Status:
COMPLETED
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients
Lead Sponsor:
Norwegian University of Science and Technology
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a double -blind randomized crossover study to provide evidence for the expert advice based recommendation of the Expert Working Group of the European Association for Palliative Care (EAPC) tha...
Detailed Description
PROTOCOL Double bedtime dosing during immediate-release morphine administration to cancer patients: A randomized, double-blind cross-over comparison of a double bedtime dose versus two standard dose...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with malignant disease
- Age more than 18 year
- Regular use of oral morphine or pain that indicates start of opioids for moderate or severe pain according to the WHO guidelines for treatment of cancer pain
- Exclusion criteria
- Known morphine intolerance
- History of drug abuse
- Decreased gastrointestinal uptake of oral medications
- Pregnancy or breast-feeding
- General health condition, psychiatric disease or cognitive function failure giving that the patient is not competent to complete questionnaires.
Exclusion
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00201539
Start Date
April 1 2002
End Date
February 1 2008
Last Update
April 8 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Norwegian Univeristy of tecknology and science
Trondheim, Trondheim, Norway, 7006
2
St Olavs University Hospital
Trondheim, Norway, 7006